Merck & Co Inc (NYSE:MRK) has begun a Phase 3 clinical trial to test its experimental dengue vaccine in a pediatric ...

According to the biotech’s chief executive, Oh Sang-gi, Xafty was shown to be effective against all four serotypes of the Dengue virus in, in vitro studies, and also has activity against other ...

Portable technology captures molecules in breath to support medical care, from managing diabetes to monitoring newborn ...

Immunoprecise Antibodies Ltd. has discovered a highly conserved epitope across all four dengue virus serotypes (DENV-1, DENV-2, DENV-3 and DENV-4) using its proprietary Lensai platform powered by its ...

This study delineates the full sequence of SARS-CoV-2 spike-mediated membrane fusion and shows how S2-targeting antibodies inhibit this process, using a near-native functional fusion system and ...

Scientists have warned there is a 'severe risk' of catching a cold this week as nine million people across Britain suffer from the virus. They issued the health alert as the recent icy weather ...

In this study, four antigens from SARS-CoV-2 and dengue virus were tested for immunogenicity, antigenicity, allergenicity, and toxicity and chosen to predict dominant T- and B-cell epitopes. Methods: ...

Limited by challenges in light-atom imaging, microscopic investigations of ferroelectricity have used cation–cation displacements as a proxy for the true cation–anion distortions. Using ...

June 3, 2025 — A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, according to a new ...